11,330 Shares in Corteva, Inc. $CTVA Acquired by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC bought a new position in Corteva, Inc. (NYSE:CTVA) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 11,330 shares of the company’s stock, valued at approximately $891,000.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Harris Associates L P boosted its position in Corteva by 168.1% during the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after purchasing an additional 10,675,052 shares during the last quarter. Norges Bank acquired a new position in Corteva in the 4th quarter worth about $504,001,000. Royal Bank of Canada increased its position in Corteva by 202.1% in the 1st quarter. Royal Bank of Canada now owns 7,458,624 shares of the company’s stock worth $624,362,000 after purchasing an additional 4,989,371 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in shares of Corteva by 6,527.4% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,148,212 shares of the company’s stock worth $211,025,000 after purchasing an additional 3,100,709 shares in the last quarter. Finally, Amundi lifted its holdings in shares of Corteva by 125.3% during the 3rd quarter. Amundi now owns 3,415,554 shares of the company’s stock valued at $219,620,000 after buying an additional 1,899,248 shares during the last quarter. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Corteva Trading Up 0.7%

Shares of CTVA stock opened at $78.82 on Thursday. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $90.97. The company has a market cap of $52.59 billion, a PE ratio of 52.20, a price-to-earnings-growth ratio of 2.39 and a beta of 0.57. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The business’s 50 day moving average is $82.03 and its two-hundred day moving average is $79.79.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. During the same period in the prior year, the firm earned $2.20 EPS. Corteva’s quarterly revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities analysts predict that Corteva, Inc. will post 3.74 EPS for the current year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be paid a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s payout ratio is presently 47.68%.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on CTVA. The Goldman Sachs Group increased their price objective on Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a report on Tuesday, April 14th. Mizuho lifted their target price on shares of Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a research note on Tuesday, July 14th. BMO Capital Markets boosted their target price on shares of Corteva from $95.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday. JPMorgan Chase & Co. raised their price target on shares of Corteva from $77.00 to $83.00 and gave the company a “neutral” rating in a report on Monday. Finally, Rothschild & Co Redburn lifted their price objective on shares of Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a research note on Wednesday, April 29th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $91.38.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.